Jonathan D. West
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jonathan D. West has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Niels C. Kokot
Department of Otolaryngology-Head and Neck Surgery, University of Southern California (USC), Los Angeles, CA
5 shared publications - Oluwatobiloba Ayo‐Ajibola
Keck School of Medicine of the University of Southern California Los Angeles California USA
3 shared publications - Tamara Chambers
Department of Otolaryngology‐ Head and Neck Surgery Keck School of Medicine of the University of Southern California Los Angeles California USA
3 shared publications Ian Kim
Departments of Pediatrics and Medicine Stanford University Palo Alto California USA
2 shared publicationsJames Kim
Resident, Caruso Department of Otolaryngology - Head and Neck Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA
2 shared publications- Alex Julian
Medical Student, Keck School of Medicine, University of Southern California, Los Angeles, CA
1 shared publication
Latest Publications
- Open Access
- 30 June 2025
- Published by Wiley in Head & Neck
- Vol. 47 (11) , 3098-3105
Post‐Thyroidectomy Opioid Prescription and Risk of Persistent Opioid Use: A Propensity Matched Cohort Study
Background: This study evaluates the risk of persistent opioid use (POU) among thyroidectomy patients given postoperative opioids. Methods: Patients undergoing thyroidectomy were identified using the TriNetX Research Platform (2010–2024). Cohorts were divided based on opioid prescriptions on the day of surgery. With propensity score matching to prevent confounding bias, risk ratios were calculated for opioid prescriptions 3–9 months post‐surgery. Secondary outcomes included ED presentation, pain diagnosis, and lifetime risk of opioid use disorder, defined as significant social dysfunction due to uncontrolled use. Results: The post‐match opioid group ( n = 19,727) experienced a 4.61% risk of POU (control: 4.07%), representing a 14% higher risk of POU compared to the non‐opioid group (RR 1.14, 95% CI: [1.03, 1.25]). Opioids slightly decreased the likelihood of outpatient visits at 30 days (RR: 0.97 [0.95, 0.98]) and 90 days (RR: 0.96 [0.94, 0.97]) following surgery. There were no significant differences in ED presentation, pain diagnoses at 30 and 90 days, or lifetime OUD risk. Conclusion: Post‐thyroidectomy opioid prescription modestly increases POU risk, highlighting the need for careful patient counseling and judicious use.
- 30 June 2025
- Published by Wiley in Head & Neck
- Vol. 47 (11) , 3098-3105
Open AccessPost‐Thyroidectomy Opioid Prescription and Risk of Persistent Opioid Use: A Propensity Matched Cohort Study
Background: This study evaluates the risk of persistent opioid use (POU) among thyroidectomy patients given postoperative opioids. Methods: Patients undergoing thyroidectomy were identified using the TriNetX Research Platform (2010–2024). Cohorts were divided based on opioid prescriptions on the day of surgery. With propensity score matching to prevent confounding bias, risk ratios were calculated for opioid prescriptions 3–9 months post‐surgery. Secondary outcomes included ED presentation, pain diagnosis, and lifetime risk of opioid use disorder, defined as significant social dysfunction due to uncontrolled use. Results: The post‐match opioid group ( n = 19,727) experienced a 4.61% risk of POU (control: 4.07%), representing a 14% higher risk of POU compared to the non‐opioid group (RR 1.14, 95% CI: [1.03, 1.25]). Opioids slightly decreased the likelihood of outpatient visits at 30 days (RR: 0.97 [0.95, 0.98]) and 90 days (RR: 0.96 [0.94, 0.97]) following surgery. There were no significant differences in ED presentation, pain diagnoses at 30 and 90 days, or lifetime OUD risk. Conclusion: Post‐thyroidectomy opioid prescription modestly increases POU risk, highlighting the need for careful patient counseling and judicious use.
- Open Access
- 25 June 2025
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 10 (3) , e70182
HPV Vaccination Knowledge and Decision‐Making Among Adults 27 to 45 Years: A Large Online Survey
Objective: Understand knowledge and barriers to human papillomavirus (HPV) vaccination among United States (US) adults, comparing adults in the original age cohort of 18–26 years to those in the expanded 27–45‐yearyear‐old cohort.Methods: A cross‐sectional survey was administered to US adults recruited through social media. Descriptive statistics characterized the data. Multivariate logistic regression identified factors associated with vaccination.Results: Among 1735 respondents, the majority were in the 27–45 age group (936, 53.94%). The 27–45‐year group exhibited more knowledge of HPV's link to head and neck cancer and vaccine protection but expressed less concern about HPV infection (all p < 0.05). Key motivators for the history of vaccination in the 27–45 year cohort included vaccine effectiveness (48.65%) and prior knowledge (42.44%). Self‐vaccination rates were comparable across age groups (18–26: 70.62% vs. 27–45: 68.07%, p = 0.256). Older adults were less likely to vaccinate dependents (68.57% vs. 75.00%, p < 0.001) despite higher interest (p < 0.001). Main barriers for unvaccinated 27–45 year old adults included scheduling issues, insurance coverage, and lack of concern for HPV infection (all p < 0.05). Among individuals aged 27 to 45, multivariate logistic regression analysis revealed significantly higher odds of vaccination in those from the Western US (compared to Northeast/Midwest) (OR 3.15, 95% CI: [1.84, 5.39]) and personal history of head and neck cancer (3.01, [1.78–5.09]).Conclusion: Most respondents understand HPV risks and are vaccinated. Interventions directed towards education about vaccine safety, the hazards of HPV, and improving access may increase vaccination.Level of Evidence: IV.
- 25 June 2025
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 10 (3) , e70182
Open AccessHPV Vaccination Knowledge and Decision‐Making Among Adults 27 to 45 Years: A Large Online Survey
Objective: Understand knowledge and barriers to human papillomavirus (HPV) vaccination among United States (US) adults, comparing adults in the original age cohort of 18–26 years to those in the expanded 27–45‐yearyear‐old cohort.Methods: A cross‐sectional survey was administered to US adults recruited through social media. Descriptive statistics characterized the data. Multivariate logistic regression identified factors associated with vaccination.Results: Among 1735 respondents, the majority were in the 27–45 age group (936, 53.94%). The 27–45‐year group exhibited more knowledge of HPV's link to head and neck cancer and vaccine protection but expressed less concern about HPV infection (all p < 0.05). Key motivators for the history of vaccination in the 27–45 year cohort included vaccine effectiveness (48.65%) and prior knowledge (42.44%). Self‐vaccination rates were comparable across age groups (18–26: 70.62% vs. 27–45: 68.07%, p = 0.256). Older adults were less likely to vaccinate dependents (68.57% vs. 75.00%, p < 0.001) despite higher interest (p < 0.001). Main barriers for unvaccinated 27–45 year old adults included scheduling issues, insurance coverage, and lack of concern for HPV infection (all p < 0.05). Among individuals aged 27 to 45, multivariate logistic regression analysis revealed significantly higher odds of vaccination in those from the Western US (compared to Northeast/Midwest) (OR 3.15, 95% CI: [1.84, 5.39]) and personal history of head and neck cancer (3.01, [1.78–5.09]).Conclusion: Most respondents understand HPV risks and are vaccinated. Interventions directed towards education about vaccine safety, the hazards of HPV, and improving access may increase vaccination.Level of Evidence: IV.
- Open Access
- 24 September 2024
- Published by SAGE Publications in Ear, Nose & Throat Journal
- Vol. 103 (2_suppl) , 22S-25S
Awake Tracheostomy in a Pediatric Patient
Awake tracheostomy is rare in the pediatric population. We describe the case of a 10-year-old male who underwent awake tracheostomy due to airway obstruction from an oropharyngeal rhabdomyosarcoma. Given the varying medical understanding and communication skills in children, advanced planning and interdisciplinary collaboration are essential to keep the patient calm and safe during awake tracheostomy.
- 24 September 2024
- Published by SAGE Publications in Ear, Nose & Throat Journal
- Vol. 103 (2_suppl) , 22S-25S
Open AccessAwake Tracheostomy in a Pediatric Patient
Awake tracheostomy is rare in the pediatric population. We describe the case of a 10-year-old male who underwent awake tracheostomy due to airway obstruction from an oropharyngeal rhabdomyosarcoma. Given the varying medical understanding and communication skills in children, advanced planning and interdisciplinary collaboration are essential to keep the patient calm and safe during awake tracheostomy.
- Open Access
- 8 February 2024
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 170 (6) , 1684-1695
Associations Between Risk Perception and HPV Knowledge and Vaccine Uptake: Highlighting the LGBTQ+ Population
Introduction: Gay and bisexual males and other LGBTQ+ communities are more frequently exposed to factors associated with an increased risk of human papillomavirus (HPV) acquisition. Vaccination is critical to protect against HPV+ head and neck cancer (HNC). We characterized the association of perceived level of risk of contraction with HPV knowledge, and vaccine decision‐making.Study Design: Cross‐sectional cohort.Setting: LGBTQ and general survey Reddit forums (control).Methods: A survey was shared amongst the online forums. Descriptive statistics characterized the data. Multivariable logistic regression was used to understand factors associated with vaccination, self‐perceived high risk, and knowledge of HPV + HNC.Results: Of 718 respondents, most were female (41.09%), Caucasian (59.89%), college‐educated (33.01%), and insured (77.15%) with a mean age of 30.75 years. Half were vaccinated (49.16%), with most unvaccinated endorsing interest (60.58%). Few dependents were vaccinated (25.91%), with interest in vaccination among parents of unvaccinated children (38.58%). Knowledge of HIV's association with HPV (62.95%), HPV causing HNC (55.57%), and the vaccine's efficacy against HNC (55.57%) was also moderate. Identifying female (P = .042), a self‐perceived high‐risk (P < .001), and having vaccinated children (P < .001) increased vaccination likelihood; transgender (P = .021), or lesbian or gay sexual identity (P < .001) decreased likelihood. Personal HNC diagnosis (P < .001), self‐vaccination (P < .001), having vaccinated children (P < .001), having anal sex (P = .001) or no knowledge of past HPV status (P < .001) increased likelihood of high self‐perceived risk.Conclusion: Efforts to improve public education regarding the association between HPV and HNC and vaccination efficacy are required to better inform vaccine decision‐making among individuals at risk for HPV infection.
- 8 February 2024
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 170 (6) , 1684-1695
Open AccessAssociations Between Risk Perception and HPV Knowledge and Vaccine Uptake: Highlighting the LGBTQ+ Population
Introduction: Gay and bisexual males and other LGBTQ+ communities are more frequently exposed to factors associated with an increased risk of human papillomavirus (HPV) acquisition. Vaccination is critical to protect against HPV+ head and neck cancer (HNC). We characterized the association of perceived level of risk of contraction with HPV knowledge, and vaccine decision‐making.Study Design: Cross‐sectional cohort.Setting: LGBTQ and general survey Reddit forums (control).Methods: A survey was shared amongst the online forums. Descriptive statistics characterized the data. Multivariable logistic regression was used to understand factors associated with vaccination, self‐perceived high risk, and knowledge of HPV + HNC.Results: Of 718 respondents, most were female (41.09%), Caucasian (59.89%), college‐educated (33.01%), and insured (77.15%) with a mean age of 30.75 years. Half were vaccinated (49.16%), with most unvaccinated endorsing interest (60.58%). Few dependents were vaccinated (25.91%), with interest in vaccination among parents of unvaccinated children (38.58%). Knowledge of HIV's association with HPV (62.95%), HPV causing HNC (55.57%), and the vaccine's efficacy against HNC (55.57%) was also moderate. Identifying female (P = .042), a self‐perceived high‐risk (P < .001), and having vaccinated children (P < .001) increased vaccination likelihood; transgender (P = .021), or lesbian or gay sexual identity (P < .001) decreased likelihood. Personal HNC diagnosis (P < .001), self‐vaccination (P < .001), having vaccinated children (P < .001), having anal sex (P = .001) or no knowledge of past HPV status (P < .001) increased likelihood of high self‐perceived risk.Conclusion: Efforts to improve public education regarding the association between HPV and HNC and vaccination efficacy are required to better inform vaccine decision‐making among individuals at risk for HPV infection.
- Open Access
- 31 May 2023
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 8 (4) , 921-929
Opioid‐limiting legislation and prescribing habits of otolaryngologists among Medicare beneficiaries
Objectives: To identify changes in otolaryngologists' opioid prescribing trends for Medicare beneficiaries associated with the enactment of state laws that limit the duration of prescriptions to 3-7 days in the years 2016 and 2017 in the United States.Methods: Through the Centers for Medicare and Medicaid Services (CMS) database, we retrieved data on Medicare enrollment and on the total days prescribed and total number of beneficiaries for the drugs codeine/acetaminophen, hydrocodone/acetaminophen, oxycodone HCl, oxycodone/acetaminophen, and tramadol HCl, by each otolaryngologist prescriber in 13 states from January 2013 to December 2019. We modeled trends using linear spline regression models that controlled for Medicare beneficiaries' state-level socio-demographic characteristics' fixed effects.Results: Across the 13 states, the number of days of all five opioids prescribed per beneficiary declined by 8.35 (SD = 12.61). The most commonly prescribed opioid type by otolaryngologists during the 5-year study period was tramadol HCl (28.72 days/beneficiary) followed by oxycodone HCl (19.99 days/beneficiary). All opioids had declines in prescription days over this time window and higher rates of decline in the years following law passage. Four states experienced statistically significant declines in the prescriptions of all opioids after the year of legislation passage (p < .05). Some states that had the greatest inclines in opioid prescriptions in the years prior to law enactment also experienced the greatest reductions in the time after legislation enactment.Conclusions: Opioid prescribing practices of otolaryngologists may have been affected by opioid prescription duration limiting laws passed in 13 states in 2016 and 2017.
- 31 May 2023
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 8 (4) , 921-929
Open AccessOpioid‐limiting legislation and prescribing habits of otolaryngologists among Medicare beneficiaries
Objectives: To identify changes in otolaryngologists' opioid prescribing trends for Medicare beneficiaries associated with the enactment of state laws that limit the duration of prescriptions to 3-7 days in the years 2016 and 2017 in the United States.Methods: Through the Centers for Medicare and Medicaid Services (CMS) database, we retrieved data on Medicare enrollment and on the total days prescribed and total number of beneficiaries for the drugs codeine/acetaminophen, hydrocodone/acetaminophen, oxycodone HCl, oxycodone/acetaminophen, and tramadol HCl, by each otolaryngologist prescriber in 13 states from January 2013 to December 2019. We modeled trends using linear spline regression models that controlled for Medicare beneficiaries' state-level socio-demographic characteristics' fixed effects.Results: Across the 13 states, the number of days of all five opioids prescribed per beneficiary declined by 8.35 (SD = 12.61). The most commonly prescribed opioid type by otolaryngologists during the 5-year study period was tramadol HCl (28.72 days/beneficiary) followed by oxycodone HCl (19.99 days/beneficiary). All opioids had declines in prescription days over this time window and higher rates of decline in the years following law passage. Four states experienced statistically significant declines in the prescriptions of all opioids after the year of legislation passage (p < .05). Some states that had the greatest inclines in opioid prescriptions in the years prior to law enactment also experienced the greatest reductions in the time after legislation enactment.Conclusions: Opioid prescribing practices of otolaryngologists may have been affected by opioid prescription duration limiting laws passed in 13 states in 2016 and 2017.
- 10 March 2023
- Published by Elsevier in Journal of Voice
- Vol. 39 (4) , 954-957
Local Reaction Causing Airway Compromise Following Vocal Fold Injection Augmentation with Carboxymethylcellulose
- 10 March 2023
- Published by Elsevier in Journal of Voice
- Vol. 39 (4) , 954-957
Local Reaction Causing Airway Compromise Following Vocal Fold Injection Augmentation with Carboxymethylcellulose
- 25 April 2022
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 80 (8) , 1424-1433
Use of ICG Angiography in Head and Neck Reconstruction With the Supraclavicular Artery Island Flap
- 25 April 2022
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 80 (8) , 1424-1433
Use of ICG Angiography in Head and Neck Reconstruction With the Supraclavicular Artery Island Flap
- 1 August 2021
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 79 (8) , 1760-1768
Risk Factors for Plate Extrusion After Mandibular Reconstruction With Vascularized Free Flap
- 1 August 2021
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 79 (8) , 1760-1768
Risk Factors for Plate Extrusion After Mandibular Reconstruction With Vascularized Free Flap
- 9 May 2020
- Published by Wiley in The Laryngoscope
- Vol. 131 (2) , E440-E442
Squamous Cell Carcinoma Metastasis to the Supraclavicular Artery Island Flap Donor Site
A rare complication of flap reconstruction following oncologic ablation is metastasis to the donor site. We present a novel case of cutaneous squamous cell carcinoma (SCCA) recurrence at the right upper‐extremity donor site following tonsillar SCCA resection with supraclavicular artery island flap reconstruction. Following surgery, the patient presented with cutaneous recurrence at the right upper‐extremity donor site. Biopsy confirmed metastasis from the oropharyngeal primary. The patient developed two subsequent right upper‐extremity recurrences before he died. The most likely mechanism of metastasis is direct implantation via contamination. This case demonstrates the importance of maintaining separate surgical fields and instruments during oncologic ablation and reconstruction. Laryngoscope, 131:E440–E442, 2021
- 9 May 2020
- Published by Wiley in The Laryngoscope
- Vol. 131 (2) , E440-E442
Squamous Cell Carcinoma Metastasis to the Supraclavicular Artery Island Flap Donor Site
A rare complication of flap reconstruction following oncologic ablation is metastasis to the donor site. We present a novel case of cutaneous squamous cell carcinoma (SCCA) recurrence at the right upper‐extremity donor site following tonsillar SCCA resection with supraclavicular artery island flap reconstruction. Following surgery, the patient presented with cutaneous recurrence at the right upper‐extremity donor site. Biopsy confirmed metastasis from the oropharyngeal primary. The patient developed two subsequent right upper‐extremity recurrences before he died. The most likely mechanism of metastasis is direct implantation via contamination. This case demonstrates the importance of maintaining separate surgical fields and instruments during oncologic ablation and reconstruction. Laryngoscope, 131:E440–E442, 2021